A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer
Clinical trial NCT00929240 · COMPLETED
Trial details
- NCT number
- NCT00929240
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2014-06-01
- Enrollment
- 287
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.